Nichiban Co., Ltd. (JP:4218)
:4218
Top Page
Nichiban Co., Ltd.
(4218)
Select Model
Select Model
Rating:57Neutral
Price Target:
¥2,043.00
▲(2.25% Upside)
Action:ReiteratedDate:10/01/25
The overall score of 57 is primarily influenced by a mixed to bearish technical outlook, as the stock is trading below most key moving averages and the MACD indicates negative momentum. This is partially offset by a moderate valuation, supported by a reasonable P/E ratio and a consistent dividend yield.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.
Negative Factors
Free Cash Flow Decline
A decline in free cash flow can limit the company's ability to fund new projects or return capital to shareholders, potentially impacting future growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.
Read all positive factors
Nichiban Co., Ltd. (4218) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥39.56B
Dividend Yield1.77%
Average Volume (3M)13.87K
Price to Earnings (P/E)16.7
Beta (1Y)0.50
Revenue Growth5.03%
EPS Growth8.02%
CountryJP
Employees1,270
SectorIndustrials
Sector Strength72
IndustryBusiness Equipment & Supplies
Share Statistics
EPS (TTM)30.00
Shares Outstanding20,738,007
10 Day Avg. Volume15,410
30 Day Avg. Volume13,873
Financial Highlights & Ratios
PEG Ratio2.56
Price to Book (P/B)0.95
Price to Sales (P/S)0.83
P/FCF Ratio17.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)97
Revenue Forecast (FY)¥51.38B
Nichiban Co., Ltd. Business Overview & Revenue Model
Company Description
Nichiban Co., Ltd. manufactures and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, dressing tapes, first-aid bandages, hemostatic bandages, and others. The company also provides OTC produ...
How the Company Makes Money
Nichiban Co., Ltd. generates revenue through the manufacturing and sale of its adhesive products. The company's primary revenue streams include the industrial sector, where it provides specialized adhesive tapes used in manufacturing and construct...
Nichiban Co., Ltd. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.86B | 49.46B | 46.86B | 45.56B | 43.13B | 41.34B |
| Gross Profit | 15.05B | 14.90B | 13.87B | 12.97B | 13.50B | 13.18B |
| EBITDA | 5.80B | 5.73B | 4.87B | 4.37B | 5.00B | 4.34B |
| Net Income | 2.02B | 1.96B | 1.83B | 2.37B | 1.81B | 1.35B |
Balance Sheet | ||||||
| Total Assets | 67.40B | 68.58B | 69.01B | 69.92B | 65.12B | 62.01B |
| Cash, Cash Equivalents and Short-Term Investments | 15.76B | 14.66B | 13.40B | 15.11B | 14.20B | 13.90B |
| Total Debt | 2.18B | 2.12B | 2.13B | 2.14B | 2.15B | 2.12B |
| Total Liabilities | 24.64B | 25.39B | 27.30B | 29.31B | 26.16B | 23.93B |
| Stockholders Equity | 42.76B | 43.19B | 41.70B | 40.60B | 38.96B | 38.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.35B | -439.00M | 338.00M | 1.52B | 3.83B |
| Operating Cash Flow | 0.00 | 3.69B | 3.19B | 2.92B | 4.06B | 5.91B |
| Investing Cash Flow | 0.00 | -1.70B | -3.69B | -1.15B | -2.90B | -3.07B |
| Financing Cash Flow | 0.00 | -763.00M | -1.23B | -867.00M | -691.00M | -772.00M |
Nichiban Co., Ltd. Technical Analysis
Positive
1998.00
Price Trends
1903.03
Positive
1917.32
Negative
1917.73
Negative
Market Momentum
0.73
Negative
55.69
Neutral
69.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4218, the sentiment is Positive. The current price of 1998 is above the 20-day moving average (MA) of 1876.33, above the 50-day MA of 1903.03, and above the 200-day MA of 1917.73, indicating a neutral trend. The MACD of 0.73 indicates Negative momentum. The RSI at 55.69 is Neutral, neither overbought nor oversold. The STOCH value of 69.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4218.
Nichiban Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥173.70B | 15.37 | ― | 2.56% | -0.26% | 3.35% | |
71 Outperform | ¥127.90B | 19.05 | ― | 2.09% | 6.39% | -34.84% | |
70 Neutral | ¥4.00B | -199.56 | ― | 2.03% | 3.24% | ― | |
67 Neutral | ¥389.24B | 18.13 | 8.83% | 2.33% | 6.29% | 8.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥23.46B | 17.72 | ― | 1.69% | -2.71% | ― | |
57 Neutral | ¥39.56B | 16.66 | ― | 1.77% | 5.03% | 8.02% |
* Industrials Sector Average
JP:4218
Nichiban Co., Ltd.
1,909.00
-6.38
-0.33%
JP:7984
Kokuyo Co
907.10
256.36
39.39%
JP:7846
Pilot Corporation
4,958.00
1,076.20
27.72%
JP:7962
King Jim Co., Ltd.
824.00
-12.26
-1.47%
JP:7975
LIHIT LAB., INC.
1,178.00
106.27
9.92%
JP:7976
Mitsubishi Pencil Company, Limited
2,469.00
160.42
6.95%
Nichiban Co., Ltd. Corporate Events
Nichiban Co., Ltd. Reports Mixed Financial Results for H1 2025
Nov 11, 2025
Nichiban Co., Ltd. reported its consolidated financial results for the six months ending September 30, 2025, showing a modest increase in net sales by 1.6% compared to the previous year. However, the company experienced declines in operating profi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.